Background <p>Postoperative complications (POCs) are associated with poor long-term outcomes in gastric cancer. However, the underlying biologic mechanisms remain unclear, and systemic inflammation may mediate this association.</p> Methods <p>This study retrospectively analyzed 4177 gastric cancer patients who underwent curative gastrectomy between 2013 and 2018. The neutrophil-to-lymphocyte ratio (NLR) was assessed preoperatively (pre-NLR), on postoperative day 2 (early NLR), and 3 months postoperatively (late NLR). Multivariable Cox and logistic regression models assessed the associations of NLR and POCs with survival and complication risk.</p> Results <p>For 20.3% of the patients, POCs occurred and were associated with significantly higher NLR at all time points. In the multivariable analysis, early and late NLR independently predicted complication risk. In the Kaplan–Meier survival analysis, POCs were significantly associated with worse overall survival (OS) (hazard ratio [HR], 1.80; <i>p</i> &lt; 0.001) and disease-specific survival (DSS) (HR, 1.80; <i>p</i> &lt; 0.001). However, in multivariate COX regression, POCs were not independently associated with OS or DSS, whereas late NLR remained a significant predictor for both OS (HR, 1.02; <i>p</i> = 0.049) and DSS (HR, 1.03; <i>p</i> = 0.008). When stratified by POC status, high late NLR was significantly associated with worse OS (HR, 2.776; <i>p</i> &lt; 0.001) and DSS (HR, 2.677; <i>p</i> &lt; 0.001) in the POC group. In the no-POC group, high late NLR also was associated with worse OS (HR, 1.587; <i>p</i> &lt; 0.001), but not DSS (HR, 1.274; <i>p</i> = 0.150).</p> Conclusions <p>Persistent systemic inflammation, reflected by elevated late NLR, is a key mediator of the relationship between POCs and survival. Monitoring persistent inflammation may improve risk stratification and guide management strategies for gastric cancer patients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Persistent Systemic Inflammation Mediates the Impact of Postoperative Complications on Survival After Gastric Cancer Surgery

  • Jane Chungyoon Kim,
  • Hyuk-Joon Lee,
  • Min Kyu Kang,
  • Kyoyoung Park,
  • Sa-Hong Kim,
  • Jeesun Kim,
  • Sung Min Kim,
  • Yo-Seok Cho,
  • Dong-Seok Han,
  • Hye Seong Ahn,
  • Seong-Ho Kong,
  • Do Joong Park,
  • Han-Kwang Yang

摘要

Background

Postoperative complications (POCs) are associated with poor long-term outcomes in gastric cancer. However, the underlying biologic mechanisms remain unclear, and systemic inflammation may mediate this association.

Methods

This study retrospectively analyzed 4177 gastric cancer patients who underwent curative gastrectomy between 2013 and 2018. The neutrophil-to-lymphocyte ratio (NLR) was assessed preoperatively (pre-NLR), on postoperative day 2 (early NLR), and 3 months postoperatively (late NLR). Multivariable Cox and logistic regression models assessed the associations of NLR and POCs with survival and complication risk.

Results

For 20.3% of the patients, POCs occurred and were associated with significantly higher NLR at all time points. In the multivariable analysis, early and late NLR independently predicted complication risk. In the Kaplan–Meier survival analysis, POCs were significantly associated with worse overall survival (OS) (hazard ratio [HR], 1.80; p < 0.001) and disease-specific survival (DSS) (HR, 1.80; p < 0.001). However, in multivariate COX regression, POCs were not independently associated with OS or DSS, whereas late NLR remained a significant predictor for both OS (HR, 1.02; p = 0.049) and DSS (HR, 1.03; p = 0.008). When stratified by POC status, high late NLR was significantly associated with worse OS (HR, 2.776; p < 0.001) and DSS (HR, 2.677; p < 0.001) in the POC group. In the no-POC group, high late NLR also was associated with worse OS (HR, 1.587; p < 0.001), but not DSS (HR, 1.274; p = 0.150).

Conclusions

Persistent systemic inflammation, reflected by elevated late NLR, is a key mediator of the relationship between POCs and survival. Monitoring persistent inflammation may improve risk stratification and guide management strategies for gastric cancer patients.